Normal granulocyte infusion therapy for aspergillosis in chronic granulomatous disease.
D000666:Amphotericin B / Q000627:therapeutic use; D001228:Aspergillosis / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D001232:Aspergillus fumigatus / Q000302:isolation & purification; D001770:Blood Bactericidal Activity; D001803:Blood Transfusion; D002648:Child; D004077:Digoxin / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007962:Leukocytes; D008297:Male; D010585:Phagocyte Bactericidal Dysfunction / Q000150:complications*; D011014:Pneumonia / Q000209:etiology / Q000628:therapy*
D005839:Gentamicins; D004077:Digoxin; D000666:Amphotericin B